Marianne P. Allen

Array ( [id] => 4825718 [patent_doc_number] => 20080124753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'SpiceMatrix Technology for Taste Compound Identification' [patent_app_type] => utility [patent_app_number] => 11/940752 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10704 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124753.pdf [firstpage_image] =>[orig_patent_app_number] => 11940752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472084 [patent_doc_number] => 20100041064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'DIAGNOSIS AND RISK STRATIFICATION OF INFECTIONS AND CHRONIC DISEASES OF THE RESPIRATORY TRACT AND LUNGS BY MEANS OF PROVASOPRESSIN, PARTICULARLY COPEPTIN OR NEUROPHYSIN II' [patent_app_type] => utility [patent_app_number] => 12/514524 [patent_app_country] => US [patent_app_date] => 2007-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4136 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041064.pdf [firstpage_image] =>[orig_patent_app_number] => 12514524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222437 [patent_doc_number] => 20100056445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA' [patent_app_type] => utility [patent_app_number] => 12/446773 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27559 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056445.pdf [firstpage_image] =>[orig_patent_app_number] => 12446773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740536 [patent_doc_number] => 08106008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Compositions and methods for arthrodetic procedures' [patent_app_type] => utility [patent_app_number] => 12/513491 [patent_app_country] => US [patent_app_date] => 2007-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13788 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106008.pdf [firstpage_image] =>[orig_patent_app_number] => 12513491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965969 [patent_doc_number] => 20080108789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'DNA & protein binding miniature proteins' [patent_app_type] => utility [patent_app_number] => 11/982657 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19317 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108789.pdf [firstpage_image] =>[orig_patent_app_number] => 11982657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887547 [patent_doc_number] => 20080261879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Method of inducing and maintaining neuronal cells' [patent_app_type] => utility [patent_app_number] => 11/981846 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18522 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261879.pdf [firstpage_image] =>[orig_patent_app_number] => 11981846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869249 [patent_doc_number] => 08957022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/446511 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21576 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629893 [patent_doc_number] => 08361966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Use of interleukin-11 as therapeutic agent for heart disease' [patent_app_type] => utility [patent_app_number] => 12/312077 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6766 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12312077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702982 [patent_doc_number] => 08088736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'CTLA-4 protein variants' [patent_app_type] => utility [patent_app_number] => 12/446216 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10207 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088736.pdf [firstpage_image] =>[orig_patent_app_number] => 12446216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596485 [patent_doc_number] => 07982018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Modified corticotropin releasing factor peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/873291 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18073 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982018.pdf [firstpage_image] =>[orig_patent_app_number] => 11873291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340156 [patent_doc_number] => 08242080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface' [patent_app_type] => utility [patent_app_number] => 12/444914 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 22 [patent_no_of_words] => 18185 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12444914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675690 [patent_doc_number] => 20080213319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'CHEMOREPULSION OF CELLS' [patent_app_type] => utility [patent_app_number] => 11/867290 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14372 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213319.pdf [firstpage_image] =>[orig_patent_app_number] => 11867290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701549 [patent_doc_number] => 08394771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-03-12 [patent_title] => 'Multimeric proteins and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 11/866960 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25276 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11866960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6492580 [patent_doc_number] => 20100093621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/442927 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23881 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093621.pdf [firstpage_image] =>[orig_patent_app_number] => 12442927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727251 [patent_doc_number] => 20080206794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Systems And Methods For Characterizing Contrast Induced-Nephropathy' [patent_app_type] => utility [patent_app_number] => 11/856458 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17331 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206794.pdf [firstpage_image] =>[orig_patent_app_number] => 11856458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772604 [patent_doc_number] => 20080058263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins' [patent_app_type] => utility [patent_app_number] => 11/846337 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 55423 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058263.pdf [firstpage_image] =>[orig_patent_app_number] => 11846337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257639 [patent_doc_number] => 08207115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Treatment of cartilage disorders with FGF-18' [patent_app_type] => utility [patent_app_number] => 12/374488 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14563 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410644 [patent_doc_number] => 20090124543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'ACTIVITY DEPENDENT NEUROTROPHIC FACTOR III (ADNF III)' [patent_app_type] => utility [patent_app_number] => 11/838128 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 35218 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124543.pdf [firstpage_image] =>[orig_patent_app_number] => 11838128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292190 [patent_doc_number] => 07544479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Method for identifying MLK inhibitors for treatment of neurological conditions' [patent_app_type] => utility [patent_app_number] => 11/881441 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12922 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544479.pdf [firstpage_image] =>[orig_patent_app_number] => 11881441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733771 [patent_doc_number] => 20080050750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Screening Assay for Inhibitors of TRPA1 Activation by a Lower Alkyl Phenol' [patent_app_type] => utility [patent_app_number] => 11/828955 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12947 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050750.pdf [firstpage_image] =>[orig_patent_app_number] => 11828955 [rel_patent_id] =>[rel_patent_doc_number] =>)